SCHEMBL6996556

SCHEMBL6996556

CCOC(=O)CCCC(=O)c1ccc2c(c1)N=C(N)C(C)O2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 3/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
TNF P01375 3/20 0.33
CTNNB1 P35222 2/20 0.33
WNT3A P56704 2/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A2 P05177 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GAA P10253 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7713364 0.78 ALDH1A1 (0.38) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL7001011 0.75 SMYD3 (0.48) ALDH1A1SMN1; SMN2GAA
SCHEMBL7713400 0.74 ALDH1A1 (0.44) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL6996551 0.70 ALDH1A1 (0.45) NPC1ALDH1A1MAPTKMT2ANPSR1
SCHEMBL14842796 0.68 KMT2A (0.65) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL2743316 0.68 NPC1 (0.57) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL7240961 0.68 TSHR (0.48) NPC1ALDH1A1MAPTSMN1; SMN2L3MBTL1
SCHEMBL30420736 0.67 SMN1; SMN2 (0.58) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL27568226 0.66 NPC1 (0.51) NPC1ALDH1A1MAPTHPGDKMT2A
SCHEMBL2743418 0.66 CTNNB1 (0.54) NPC1ALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed